From Yale: “Cellular clean-up can also sweep away forms of cancer”

Yale University bloc

Yale University

November 9, 2017
Bill Hathaway

1
Cells treated (right) or untreated (left) with a PROTAC that degrades the target protein (green). No image credit.

Two new research papers reinforce the benefits of a novel therapy that hijacks the cell’s own protein degradation machinery to destroy cancer cells, Yale researchers report Nov. 9 in the journal Cell Chemical Biology.

The new approach to drug discovery, called Proteolysis Targeting Chimeras or PROTACs, was developed in the laboratory of Craig Crews, the Lewis B. Cullman Professor of Molecular, Cellular, and Developmental Biology, professor of chemistry and pharmacology, as well as executive director of the Yale Center for Molecular Discovery.

The system engages the cell’s own protein degradation machinery to destroy targeted proteins by tagging them for removal. Most drugs are based on the ability of small molecules to bind to and block the function of disease-causing proteins, but some proteins are resistant to such intervention.

“This system will help us change the current small-molecule drug paradigm that fails to target 75% of rogue proteins,” said Crews, scientific founder of Arvinas LLC, the New Haven biotechnology company developing the concept.

The first paper, [Cell Chemical Biology] shows for the first time that PROTAC system can target mutant RTK proteins, which have been linked to several forms of cancer. The second paper [Cell Chemical Biology] proves that the PROTAC system can target rogue proteins with greater specificity than traditional approaches.

Yale’s George M. Burslem and Blake E. Smith are first authors of the first paper. Smith and Yale’s Daniel P. Bondeson are co-first authors of the second paper.

The two papers were primarily funded by the National Institutes of Health. Crews is a shareholder of Arvinas, which also provided researchers to the projects.

See the full article here .

Please help promote STEM in your local schools.

STEM Icon

Stem Education Coalition

Yale University Campus

Yale University comprises three major academic components: Yale College (the undergraduate program), the Graduate School of Arts and Sciences, and the professional schools. In addition, Yale encompasses a wide array of centers and programs, libraries, museums, and administrative support offices. Approximately 11,250 students attend Yale.